STAT

In public, lawmakers scold drug distributors. Come campaign season, they accept their cash willingly

Lawmakers have publicly shamed drug distributors for their role in the opioid crisis. But that hasn’t kept them from accepting more of the industry's campaign cash.
Rep. Frank Pallone (D-N.J.)

WASHINGTON — In this election season, lawmakers are taking on drug distributors with abandon, and many seem to relish the role.

“I just want you to feel shame,” one member of Congress said in May to five executives of major drug wholesalers, which are accused of worsening the opioid crisis by dumping thousands of addictive painkillers into small towns.

“Enough is enough,” said another. “We expect you to do more.”

If blanketing Capitol Hill with cash counts as “doing more,” the distributors are fulfilling their mandate.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Roche Obesity Drug, An Experimental Lilly Insulin, And More
Roche disclosed that its recently acquired experimental obesity medication helped people lose a significant amount of weight in a Phase 1 trial.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.

Related Books & Audiobooks